43 results
Keyword Phentermine Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Qsiva
phentermine, topiramate, Obesity
Date of refusal: 14/05/2013, Refused, Last updated: 13/06/2013Refused phenterminetopiramate Overview On 18 October 2012 … contains the active substances phentermine and topiramate. It was to … are appetite suppressants. Phentermine suppresses appetite by releasing … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): phentermine, topiramate
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Endocrinology, -gynacology-fertility-metabolism
PIP number: EMEA-000826-PIP01-09, Route(s) of administration: Oral use, Pharmaceutical form(s): Capsule, hard
Decision date: 29/10/2010, Last updated: 25/11/2010, Compliance check: XKey facts phentermine topiramate Endocrinology … granting of a waiver for phentermine / topiramate, (EMEA-000 … granting of a waiver for phentermine / topiramate, (EMEA-000826-PIP01-09 … -
List item
Referral: Anorectics
phentermine, amfepramome, clobenzorex, dexfenfluramine, fenbutrazate, fenfluramine, fenproporex, mazindol, mefenorex, norpseudoephedrine, phenmetrazine, phendimetrazine, propylhexedrine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 16/02/1996, EC decision date: 09/12/1996, Last updated: 10/12/1996Phendimetrazine, Phenmetrazine, Phentermine • Type II Substances: Dexfenfluramine … 108), Phenmetrazine (109), Phentermine (103) 1/2 Annex I AMENDMENTS … phentermine amfepramome clobenzorex de … -
List item
National expert: Giuseppe Pimpinella, Italian Medicines Agency (updated)
- Declaration of interests - 79.96 KB | PDF
- Curriculum Vitae - 20.87 KB | PDF
MALGARINI R, PIMPINELLA G. Phentermine and topiramate in the treatment … -
List item
Human medicine European public assessment report (EPAR): DaTSCAN
ioflupane (123l), Tomography, Emission-Computed, Single-Photon, Lewy Body Disease, Parkinson Disease, Alzheimer Disease
Date of authorisation: 27/07/2000, Revision: 22, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): Xenical
orlistat, Obesity
Date of authorisation: 29/07/1998, Revision: 24, Authorised, Last updated: 07/05/2020 -
List item
Human medicine European public assessment report (EPAR): Fintepla
Fenfluramine hydrochloride, Epilepsies, Myoclonic
Date of authorisation: 18/12/2020,
, 
, Authorised, Last updated: 08/01/2021
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 February 2013
CHMP, Last updated: 22/02/2013Qsiva INN phentermine / topiramate Marketing-authorisation … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 October 2012
CHMP, Last updated: 19/10/2012INN phentermine / topiramate Marketing-authorisation … -
List item
Referral: Efexor depot
venlafaxine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 28/11/2008, Last updated: 20/12/2008 -
List item
Referral: Efexor
venlafaxine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 28/11/2008, Last updated: 18/12/2008 -
List item
Medicines under evaluation
Last updated: 16/03/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-5 September 2012
European Medicines Agency, London, UK, from 03/09/2012 to 05/09/2012, Last updated: 02/06/2012 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-3 October 2012
PRAC, Last updated: 05/10/2012 -
List item
Press release: Pharmacovigilance Risk Assessment Committee (PRAC) elects chair and vice-chair
PRAC, Last updated: 07/09/2012 -
List item
News: European Medicines Agency publishes list of human medicines under evaluation
Last updated: 01/03/2012Antineoplastic medicines Phentermine/topiramate Antiobesity medicines Pixantrone … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 February 2013
European Medicines Agency, London, UK, from 04/02/2013 to 07/02/2013, Last updated: 02/06/2012 -
List item
Paediatric Committee (PDCO): 8-10 September 2010
European Medicines Agency, London, UK, from 08/09/2010 to 10/09/2010, Last updated: 16/02/2010pneumology – allergology; Phentermine/topiramate, from Vivus BV, in the therapeutic … -
List item
News: 2012 annual report on EudraVigilance published
Last updated: 26/07/2013 -
List item
PRAC: Committee agendas, minutes and meeting highlights report archive 2012-2013
Last updated: 01/01/2015 -
List item
Periodic safety update reports (PSURs) (updated)
Last updated: 16/04/2021 -
List item
Reinforcing communication with patients and healthcare professionals
Belgrade, Serbia, 23/06/2014, Last updated: 08/07/2014 -
List item
Press release: Extraordinary meeting to finalise review of Anorectic Agents
Last updated: 09/09/1999substances: - amfepramone - phentermine - clobenzorex, fenproporex … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 April 2021
European Medicines Agency, Amsterdam, the Netherlands, from 06/04/2021 to 09/04/2021, Last updated: 27/02/2018 -
List item
Press release: Committee for Proprietary Medicinal Products (CPMP) 32nd plenary meeting
Last updated: 20/11/1997initiated by Belgium for phentermine and amphepramone containing …